上海药明康德新药开发有限公司 SHANGHAI PHARMATECHS CO.LTD
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
WuXi AppTec Reports Strong 2019 Annual Results 2020-03-24 18:56
WuXi AppTec Wuhan Site Resumes Operation 2020-03-11 20:00
WuXi AppTec China Sites Resume Operations after Extended Lunar New Year Holiday 2020-02-12 20:00
WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform 2020-01-13 22:00
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility 2020-01-03 08:10
WuXi AppTec Receives Investment Grade Corporate Ratings from Three Global Rating Agencies 2019-11-06 16:00
WuXi STA's Jinshan Facility Passes EMA Inspection 2019-10-28 08:00
WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules 2019-10-11 08:02
WuXi AppTec Launches DNA Encoded Library (DEL) Service Package "DELight" to Expedite Early Drug Discovery 2019-09-04 08:00
WuXi AppTec Reports First Half 2019 Interim Results 2019-08-19 19:20
WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections 2019-07-23 12:48
WuXi AppTec Named One of MIT Technology Review's 50 Smartest Companies 2019-06-29 13:26
WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development 2019-05-06 07:50
WuXi AppTec Appoints Dr. Frederick H. Hausheer as Chief Medical Officer 2019-04-08 10:00
WuXi STA's New Drug Product Manufacturing Facility Passes First European MPA GMP Inspection 2019-03-27 14:00
WuXi AppTec Reports Strong 2018 Annual Results 2019-03-22 20:47
WuXi AppTec Testing Facilities Complete Three Regulatory Inspections from US FDA, OECD, and CNAS with Excellent Results 2019-03-11 16:00
WuXi AppTec Lists H Shares on the Hong Kong Stock Exchange 2018-12-13 10:23
WuXi AppTec Expands Site in California for Pharmaceutical R&D Services 2018-12-10 16:00
WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan 2018-11-28 08:00
1 2 3 4 5 19